Archives
Showing 31 - 40 of 41 posts
https://www.coltonconsortium.org/publications/differences-in-disease-characteristics-and-treatment-exposures-between-paediatric-and-adult-onset-inflammatory-bowel-disease-using-a-registry-based-cohort/
https://www.coltonconsortium.org/publications/effect-of-bimekizumab-on-patient-reported-disease-impact-in-patients-with-psoriatic-arthritis-1-year-results-from-two-phase-3-studies/
https://www.coltonconsortium.org/publications/efficacy-and-safety-of-avacopan-in-patients-aged-65-years-and-older-with-anca-associated-vasculitis-a-post-hoc-analysis-of-data-from-the-advocate-trial/
https://www.coltonconsortium.org/publications/environmentally-driven-immune-imprinting-protects-against-allergy/
https://www.coltonconsortium.org/publications/extrarenal-symptoms-associate-with-worse-quality-of-life-in-patients-enrolled-in-the-amp-ra-sle-lupus-nephritis-network/
https://www.coltonconsortium.org/publications/clinical-and-ultrasound-features-of-a-cohort-of-psoriasis-patients-without-musculoskeletal-symptoms-a-prospective-and-multicenter-study/
https://www.coltonconsortium.org/publications/clinical-characteristics-and-outcomes-of-polyarteritis-nodosa-an-international-study/
https://www.coltonconsortium.org/publications/a-retrospective-evaluation-of-glucagon-like-peptide-1-receptor-agonists-in-systemic-lupus-erythematosus-patients/
https://www.coltonconsortium.org/publications/assessment-of-damage-in-takayasus-arteritis/
https://www.coltonconsortium.org/news/colton-consortium-sponsors-2025-faseb-autoimmunity-conference/
The Colton Consortium sponsored the 2025 FASEB Autoimmunity Conference in Niagara Falls, a leading international forum dedicated to advancing autoimmune research and fostering collaboration among scientists and clinicians worldwide.
